About The Event
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses and a training seminar, interactive group discussions, and networking options that help you engage with experts and solutions providers.
More Information
Sponsored talk
Don't miss Michael Hennig's presentation on Sept. 26th at 11:50 am in the GPCR-Based Drug Discovery track. The title will be: “Grating-coupled Interferometry supporting structure-based drug discovery on membrane proteins.”